| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | Director
3 companies
Jeffs Roger is a Chief Executive Officer at LQDA, with reported holdings spanning 3 companies. Recent filings cover 7 purchases and 31 sales. Those positions are worth an estimated $114.4M at current prices.
Our model assigns Jeffs Roger a middling insider score of 64/100, based on 25 past trades. Over a 12-month horizon, 50.0% of those trades were profitable, with an average 12-month return of -18.2%.
Jeffs Roger's largest disclosed position is in LQDA as Chief Executive Officer, worth about $102.0M. The recent filings there lean toward selling, a net 146,072 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 13, 2026 | LQDA Liquidia Corporation | Chief Executive Officer | Sale+OE | 35,249 | $71.51 | $2,520,682.83 | -1.5% | - | - | |
| Jun 11, 2026 | AXSM Axsome Therapeutics, Inc. | Director | Sell | 572 | $247.65 | $141,655.80 | -0.5% | - | - | |
| May 26, 2026 | LQDA Liquidia Corporation | Chief Executive Officer | Sell | 75,000 | $61.01 | $4,575,675.00 | -2.3% | - | - | |
| May 12, 2026 | LQDA Liquidia Corporation | Chief Executive Officer | Sell | 75,000 | $45.89 | $3,441,957.50 | -1.9% | - | - | |
| Apr 9, 2026 | LQDA Liquidia Corporation | Chief Executive Officer | Sell | 25,000 | $40.12 | $1,002,887.50 | -1.6% | +97.1% | - | |
| Jan 12, 2026 | LQDA Liquidia Corp | Chief Executive Officer | Sale+OE | 66,610 | $37.43 | $2,493,212.30 | -6.0% | +5.3% | - | |
| Oct 13, 2025 | LQDA Liquidia Corp | Chief Executive Officer | Sale+OE | 20,261 | $23.41 | $474,310.01 | -1.9% | +54.0% | - | |
| Sep 2, 2025 | AXSM Axsome Therapeutics, Inc. | Director | Sell | 13,464 | $123.68 | $1,665,227.52 | -19.0% | +20.7% | - | |
| Aug 29, 2025 | AXSM Axsome Therapeutics, Inc. | Director | Sell | 60,000 | $121.72 | $7,303,400.00 | -18.0% | +24.9% | - | |
| Aug 26, 2025 | AXSM Axsome Therapeutics, Inc. | Director | Sell | 36,694 | $120.05 | $4,405,215.52 | -11.5% | +24.8% | - |